Peering Into Regeneron Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Regeneron Pharmaceuticals's (NYSE:REGN) short percent of float has risen 6.52% since its last report, with 1.34 million shares sold short, which is 1.47% of all regular shares available for trading. An increase in short interest can signal that investors have become more bearish. However, Regeneron's short interest as a percentage of float is 3.19%, which is less than most of its peers.
August 22, 2023 | 4:45 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Increased short interest in Regeneron Pharmaceuticals indicates a bearish sentiment among investors. However, compared to its peers, the company's short interest is lower.
The increase in short interest indicates that more investors are betting against Regeneron Pharmaceuticals, which could put downward pressure on the stock price in the short term. However, the fact that the company's short interest is lower than most of its peers could mitigate this effect.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100